Injectafer® approved in the U.S. for the treatment of iron deficiency in patients with heart failure
CSL Vifor today announced that the U.S. Food and Drug Administration (FDA) has granted its partner American Regent, Inc., a Daiichi Sankyo Group company, approval for Injectafer® for the treatment of iron deficiency in adult patients with heart failure and New York Heart Association class II/III* to improve ...
United States Injectafer Ferinject Daiichi Sankyo Inc York Heart Association Functional Classification American College Of Cardiology American Regent Inc
Source: pharmiweb.com